| Literature DB >> 35464514 |
Mohammad Noor1,2, Fawad Rahim1,2, Said Amin1,2, Raza Ullah3,4, Sheraz Zafar2.
Abstract
Infectious diseases like malaria, typhoid, leptospirosis, and dengue fever are the leading causes of morbidity and mortality in developing countries like Pakistan. Although rare, it is possible to have coinfection with organisms that are endemic in a region, causing diagnostic and therapeutic dilemmas. Leptospirosis is caused by Gram-negative spirochetes. Leptospira are widely distributed and are transmitted by contamination of water and food by the urine of infected animals like rodents. Leptospirosis is characterized by fever, body aches, abdominal pain, and hepatic and renal involvement. Laboratory abnormalities include cytopenia, elevated bilirubin, alanine aminotransferase, and abnormal renal function tests. Typhoid fever is caused by Salmonella typhi (S. typhi), which is transmitted by fecal contamination of drinking water and food items. The clinical manifestations of typhoid fever include fever, abdominal pain, and diarrhea. Laboratory abnormalities include cytopenia and mildly deranged liver function tests. A strain of S. typhi resistant to all antibiotics except azithromycin and carbapenems was isolated in 2016 in Pakistan. Most of the clinical manifestations and laboratory abnormalities of leptospirosis and typhoid fever overlap. There have been case reports of coinfection of S. typhi and Leptospira, but there is no report of coinfection of extensively drug-resistant (XDR) S. typhi and Leptospira. We present a case of a 20-year-old man with fever, loose motions, and jaundice from Peshawar, Pakistan who had coinfection of Leptospira and XDR S. typhi. The attending physicians should adopt Hickam's dictum instead of Occam's razor approach.Entities:
Keywords: coexistent disease; drug susceptibility testing and antibiotic resistance; leptospira; salmonella enterica serovar typhi; xdr enteric fever
Year: 2022 PMID: 35464514 PMCID: PMC9013503 DOI: 10.7759/cureus.23295
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Preliminary Investigations at District General Hospital
g/dL: Gram/deciliter, mcL: Microliter, ELISA: Enzyme-linked immunosorbent assay, HBsAg: Hepatitis B surface antigen, HCV: Hepatitis C virus, HIV: Human immunodeficiency virus, IU/L: International unit/liter, NS: Non-structural, IgM: Immunoglobulin M, PA: Posterior-anterior
| Investigations | Reference range | Results |
| Hemoglobin (g/dL) | 13.5 – 17.5 | 11.2 |
| Platelet count (x103/mcL) | 150 – 450 | 37,000 |
| White cell count (x103/mcL) | 4.5 – 11 | 4.1 |
| Neutrophils (%) | 40 – 60 % | 81% |
| Lymphocytes (%) | 20 – 40 % | 16% |
| Monocytes (%) | 2 – 8 % | 02 % |
| Eosinophils (%) | 1 – 4 % | 01 % |
| HBsAg (ELISA) | Non-Reactive | Non-Reactive |
| Anti-HCV (ELISA) | Non-Reactive | Non-Reactive |
| Anti-HIV (ELISA) | Non-Reactive | Non-Reactive |
| Total Bilirubin (mg/dL) | 0.2 – 1.2 | 12.6 |
| Alanine aminotransferase (IU/L) | < 45 | 218 |
| Alkaline phosphatase (IU/L) | 30 – 120 | 360 |
| Dengue NS-1 antigen | Non-Reactive | Non-Reactive |
| Dengue IgM antibodies | Non-Reactive | Non-Reactive |
| Urinalysis | Normal | |
| Malarial Parasite | Not seen | |
| Ultrasound Abdomen and Pelvis | Mild hepatosplenomegaly | |
| X-Ray Chest (PA) view | Normal | |
| Bone marrow biopsy | Hypercellular bone marrow, thrombocytopenia suggestive of peripheral destruction | |
Investigations at Tertiary Care Hospital
g/dL: Gram/deciliter, mcL: Microliter, U/L: Unit/liter, mg/dL: milligram/deciliter, IU/L: International unit/liter, PCR: Polymerase chain reaction, PT: Prothrombin time, APTT: Activated partial thromboplastin time, G6PD: Glucose-6-phosphate dehydrogenase, SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2, IgM: Immunoglobulin M, IgG: Immunoglobulin G, ELISA: Enzyme-linked immunosorbent assay, NS: Non-structural
| Investigations | Reference range | Results |
| Hemoglobin (g/dL) | 13.5 – 17.5 | 10.6 |
| Platelet count (x103/mcL) | 150 – 450 | 90,000 |
| White cell count (x103/mcL) | 4.5 – 11 | 7.81 |
| Neutrophils (%) | 40 – 60 % | 77 % |
| Lymphocytes (%) | 20 – 40 % | 20 % |
| Monocytes (%) | 2 – 8 % | 02 % |
| Eosinophils (%) | 1 – 4 % | 01 % |
| Reticulocytes (%) | 0.5 – 2 % | 1.1% |
| Lactate dehydrogenase (U/L) | 140 – 280 | 712 |
| C-Reactive Protein (mg/dL) | < 0.5 | 7.2 |
| Total Bilirubin (mg/dL) | 0.2 – 1.2 | 13.4 |
| Direct Bilirubin (mg/dL) | < 0.3 | 9.9 |
| Alanine aminotransferase (IU/L) | < 45 | 184 |
| Alkaline phosphatase (IU/L) | 30 – 120 | 391 |
| S. Albumin (g/dL) | 3.4 – 5.5 | 2.0 |
| S. creatinine (mg/dL) | 0.5 – 1.2 | 0.8 |
| Urea (mg/dL) | 20 – 40 | 32 |
| PT (seconds) | 12 | 12 |
| APTT (seconds) | 32 | 30 |
| G6PD (units/gram Hb) | 5.5 – 20.5 | 1.5 |
| SARS–CoV–2 PCR | Negative | Negative |
| Anti-hepatitis ‘A’ IgM and IgG (ELISA) | Non-reactive | Non-reactive |
| Anti-leptospiral IgM (ELISA) | Non-reactive | Reactive |
| Anti-leptospiral IgG (ELISA) | Non-reactive | Non-reactive |
| Dengue NS1-Antigen and Antibodies (ELISA) | Non-reactive | Non-reactive |
| Anti-Nuclear Antibody | Non-reactive | Non-reactive |
| Coomb’s test (direct and indirect) | Negative | Negative |
| Monospot test | Negative | Negative |
| Special smear | No abnormal cells | |
| Stool examination | Numerous pus cells | |
| Echocardiography | Mild pericardial effusion | |
| Ultrasound Abdomen and pelvis | Hepatomegaly (18 cm) | |
| CT chest | Normal | |
| CT abdomen and pelvis | Hepatosplenomegaly; few mesenteric lymph nodes in the right iliac fossa, largest up to 1.4 cm | |
| Blood Culture | Gram-Negative Rods of S. typhi sensitive to Meropenem, Azithromycin. Resistant to ciprofloxacin, ceftriaxone, cefuroxime, doxycycline. | |
| Urine culture | No growth | |
| Stool culture | No growth of any pathogenic organism | |
Laboratory Investigations During Hospital Stay
g/dL: Gram/deciliter, mcL: Microliter, mg/dL: milligram/deciliter, IU/L: International unit/liter
| Reference Range | Day 3 | Day 5 | Day 7 | Day 9 | Day 11 | Day 13 | Day 14 | |
| Hemoglobin (g/dL) | 13.5 – 17.5 | 9.6 | 10.6 | 9.4 | 8.7 | 9.2 | 10.1 | 10.7 |
| Platelet count (x103/mcL) | 150 – 450 | 231 | 453 | 341 | 348 | 468 | 432 | 469 |
| White cell count (x103/mcL) | 4.5 – 11 | 6.5 | 9.4 | 8.9 | 8.6 | 8.5 | 8.8 | 8.7 |
| Total Bilirubin (mg/dL) | 0.2 – 1.2 | 12.2 | 6.8 | 5.7 | 3.3 | 2.4 | 2.0 | 1.6 |
| Alanine aminotransferase (IU/L) | < 45 | 97 | 130 | 108 | 67 | 58 | 49 | 44 |
| Alkaline phosphatase (IU/L) | 30 – 120 | 342 | 606 | 449 | 348 | 298 | 263 | 211 |